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Abstract 
Review on t(7;14)(q35;q32), inv(14)(q11q32) and 
t(14;14)(q11;q32), with data on clinics, and the 
genes involved. 
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Clinics and pathology 
Disease 
Ataxia telangiectasia (AT) 
Clinics 
AT is a rare multisystem disease characterized by 
cerebellar ataxia, immunodeficiency, sensitivity to 
ionizing radiation, chromosome instability and 
predisposition to lymphoid malignancies, including 
T-PLL. 
Cytogenetics 
 Spontaneous chromatid/chromosome breaks are 
found in this disease with a high frequency. 
 The best diagnosis test is on the highly elevated 
level (10% of mitoses) of inv(7), t(14;14) 
 Clonal rearrangement further occurs in 10% of 
patients, but without manifestation of malignancy: 
t(14;14), inv(14) or t(X;14) 
 Clonal rearrangements in T-cell ALL and T-PLL in 
AT patients are complex with the frequent 
involvement of t(14:14) or t(X;14) as is found in T-
PLL in non AT patients. 
Disease 
T Prolymphocytic leukemia (T-PLL)   
An inv(14)(q11q32.1) was found in about 80% cases 
of T-PLL. In 10%, there is t(14;14)(q11;q32.1) 
(Brito-Babapulle et al., 1991; Maljaei et al, 1998). 
Phenotype/cell stem origin 
Mature post-thymic T-cell malignancy 
 CD4+CD8- (70%) CD4+CD8+ (25%) or CD4-
CD8+ (<10%) 
 CD7+ bright and surface CD3 negative in 20% of 
cases. 
Clinics 
T-PLL is rare and affects adults, occurs slightly more 
often in men at advanced age.  
T-PLL main disease features at presentation are 
splenomegaly (79%), lymphadenopathy (46%), 
hepatomegaly (39%), skin lesion (23%), pleural 
effusion (15%) and marked lymphocytosis (> 100 X 
109/L) (72%) 
Cytology 
In 70% of cases proliferation of medium-sized 
lymphocytes with either a regular or a irregular 
nuclear outline and one single nucleolus (or absent). 
The cytoplasme is scanty, agranular, deeply 
basophilic and often with protrusions (blebs).  
In 20% of cases there are no obvious differencies 
between B and T prolymphocytes with proeminent 
nucleolus.  
In rare cases T prolymphocytes show a polylobated 
nucleus or a cerebriform configuration (as sezary 
cell) 
Cytogenetics 
Chromosomal abnormalities are detected in most T-
PLL after culture with mitogens like PHA. 
Karyotype is often complex with high degree of 
instability.  
 inv(14)(q11q32) is the most frequent chromosomal 
abnormality and occurs in more than two thirds of 
cases. 
Few patients may have t(14;14)(q11;q32). 
The variant t(X;14)(q28;q11) may be found. 
Additional Anomalies:  
 Anomalies of 11q23, where the ataxia teliangectasia 
mutated gene is located, have also been reported in 
T-PLL Anomalies of the short arm of chromosome 
12 seem to be observed with a high frequency so as 
13q14.3 deletions. 
 55 to 80 % of cases have additional abnormality 
affecting the chromosome 8 : i(8)(q10) (43%) , 
t(8;8)(p12;q11) (14%), +8 (14%) and abnormality of 
the short arm of chromosome 8 (14%). Deletions at 
12p13 and 22q and amplification of 5p are on FISH 
and/or SNP array (Hetet et al., 2000; Bug et al., 
2009; Nowak et al., 2009). Abnormalities of 
chromosomes 6 (33%) and 17 (26%) have also been 
identified by karyotyping and CGH (Brito-
Babapulle et al., 1991, Costa et al., 2003). The TP53 
gene is deleted, with overexpression of p53, in some 
cases (Brito-Babapulle et al., 2000). 
Prognosis 
T-PLL has an aggressive clinical course in most 
patients with median survival times ranging from 7 
to 30 months. Cases with a more chronic course have 
also been reported, but such cases may progress after 
2-3 years (Durig qt al., 2007). 
Disease 
Adult T-cell leukemia/lymphoma. 
Inversion inv(14)(q11q32.1) and translocation 
t(14;14)(q11;q32.1) were reported in 10 and 2 cases, 
respectively (Miyamoto et al., 1984; Fujita et al., 
1986; Sadamori et al., 1986; Sanada et al., 1987; 
Isobe et al., 1990; Sadamori et al., 1991; Kamada et 
al., 1992; Itoyama et al., 2001). 
Cytogenetics 
The karyotype is often complex. Deletion of 6q, 13q, 
trisomy 3, trisomy 7 or partial trisomy of the long 
arm of chromosome 7 are frequently found. 
Disease 
 Acute lymphoblastic leukemia (ALL) of T 
lineage. 
Cytogenetics 
Inv(14) is exceedingly rare in T cell acute 
lymphoblastic leukemia. In two cases reported, 
inv(14) coexists with other cytogenetic aberrations 
well described in T-ALL, like t(11;14)(p13;q11) and 
rearrangement at chromosome 7q34. 
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Disease 
Leukemias of B lineage. 
Cytogenetics 
Inv(14) is a exceedingly rare phenomenon in 
lymphoid malignancy of B lineage. It has been 
reported in a patient with B-cell chronic lymphocytic 
leukemia but only in a PHA stimulated bone 
marrow. Only two cases of lymphoblastic leukemia 
of B-lineage with inv(14) have been reported. These 
two cases are pre-B2 ALL (CD10+ and cytoplamic 
μ chain negative). 
Disease 
Angioimmunoblastic T-cell lymphoma. 
The translocations (7;14)(q35;q32.1), 
t(14;14)(q11;q32.1) and inversion 
inv(14)(q11q32.1) were found in 2 cases for each 
anomaly (Cosimi et al., 1990; Schlegelberger et al., 
1990; Leich et al., 2007). 
Cytogenetics 
Additional aberrations were trisomy 3, trisomy 7, 
i(7q), dup(7q). 
Disease 
Hepatosplenic T-cell lymphoma. 
Only 2 cases with translocation t(7;14)(q35;q32.1) 
(Yabe et al., 2016; Yabe et al., 2016). 
Cytogenetics 
The translocation was as a sole aberration. 
Disease 
Mycosis fungoides/ Sezary syndrome. 
The inversion inv(14)(q11q32.1) were observed in 2 
cases (Brito-Babapulle et al., 1997). 
Cytogenetics 
Complex karyotype in both cases. 
Disease 
Acute myeloid leukemia with lymphoid 
associated antigens. 
Genes involved and 
proteins 
TCL1A (T-cell leukemia/lymphoma 
1A). 
Location 
14q32.13. 
Note 
The TCL1A oncogene is located on chromosome 
14q32.1. It belongs to the TCL1 family. TCL1A 
gene is 6.5 Kb in size and contains four exons. 
TCL1B is located on 14q32.1 16 Kb centromeric of 
TCL1A and shows 60% similarity to TCL1A; 
TCL1A and TCL1B are located in the about 160 kb 
region of breakpoints observed in T-cell leukemia 
cases with translocations at 14q32.1. 
 Semi quantitative RT-PCR analysis revealed that 
both TCL1A and TCL1B genes are expressed in 
spleen, tonsil, fetal liver, fetal kidney and fetal 
thymus. However the TCL1B gene is expressed in a 
wide variety of tissues. Normally, TCL1A 
expression is observed in early T cell progenitors 
(CD4- CD8- CD3-) and lymphoid cell of the B 
lineage: pre B cells and immature IgM expressing B 
cells. 
 TCL1A, TCL1B encode for protein of about 14 
kDa. TCL1A 14 kDa protein consists of an eight-
stranded antiparallel beta barrel with a hydrophobic 
core and are predicted to bind small hydrophobic 
ligands such as retinoids, nucleosides or fatty acids. 
 : in addition to TCL1A and TCL1B the locus 
contains an additional TCL1- neighboring gene ( 
TCL6) encoding proteins of 141 and 110 amino 
acids (Saitou et al., 2000). 
MTCP1 (Mature T Cell Proliferation 1) 
Location 
Xq28 
DNA/RNA 
The MTCP1 is located at Xq28 and activated in rare 
cases of T-PLL with a t(X;14)(q28;q11) 
translocation. 
Protein 
MTCP1 encodes for two proteins p8MTCP1 and 
p13MTCP1 
TRA (T cell Receptor Alpha) 
Location 
14q11.2 
DNA/RNA 
 The size of TCR alpha/delta locus is about 1 Mb. 
The TCR delta variable (V) diversity (D) joining (J) 
and constant region genes are situated within the 
TCR alpha locus between the TCR alpha V and the 
TCR alpha J segments. 
 The TCR delta locus contains three D segments and 
four J segments, whereas the TCR alpha J regions 
spans approximately 80 Kb and contains at least 61 
segments. 
 The TCR alpha/delta locus is transcribed in a 
centromer to telomer direction. 
Protein 
T-cell receptor 
TRD (T cell Receptor Delta) 
Location 
14q11.2 
DNA/RNA 
 The size of TCR alpha/delta locus is about 1 Mb. 
The TCR delta variable (V) diversity (D) joining (J) 
and constant region genes are situated within the 
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TCR alpha locus between the TCR alpha V and the 
TCR alpha J segments. 
 The TCR delta locus contains three D segments and 
four J segments, whereas the TCR alpha J regions 
spans approximately 80 Kb and contains at least 61 
segments. 
 The TCR alpha/delta locus is transcribed in a 
centromer to telomer direction. 
Protein 
T-cell receptor 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
 TCL1A and TCL1B are expressed at very low level 
in normal bone marrow and peripheral lymphocytes 
but are activated in the T-PLL by juxtaposition to the 
T cell receptor alpha/delta locus at 14q11. 
 The another gene of TCL1 family, MTCP1 is 
activated in rare cases of T-PLL with a t(X;14) 
translocation and is also homologous to TCL1A 
gene. 
 Breakpoints at 14q32.1 involve a chromosomal 
segment of about 160 Kb and cluster in two regions. 
The centromeric region is mainly involved in 
inversions, whereas the telomeric region is involved 
in simple translocations. 
Fusion protein 
Oncogenesis 
TCL1A has been shown to promote cell proliferation 
and survival by acting as a coactivator of the protein 
kinase B (AKT), a key intracellular survival 
regulator. The protein kinase AKT, the homologue 
of v-akt isolated from the retrovirus AKT8, which 
causes T-cell lymphomas in mice, is a key player in 
transduction of antiapoptotic and proliferative 
signals in T-cell. The TCL1 protein, encoded by the 
TCL1A oncogene, interacts with the AKT, this 
interaction results in the enhancement of the AKT 
kinase activity and promotes its nuclear transport. In 
contrast, AKT kinase does not interact with the 
TCL1B protein. The biological outcome of the 
TCL1A-induced enhancement of AKT activity is 
expected to occur through the phosphorylation of 
AKT specific targets. Because the TCL1A activated 
AKT translocates into the nucleus, the most likely 
targets are nuclear. Recent work revealed that the 
TCL1A oncoprotein also inhibits activation-induced 
cell death and growth arrest by inhibiting the 
proapoptotic PRKCG and ERK pathways (Despouy 
et al., 2007; Hsi et al., 2014). 
To be noted 
A sporadic form of inv(14)(q11q32) is found 
occasionally in cultured normal lymphocytes (at the 
level of about 1/500). It involves a site specific 
recombination between the immunoglobulin heavy 
chain (IgH) variable region on 14q32.3 with TCR J 
alpha on 14q11 and probably arises from illegitimate 
recombinase joining of the rearranged genes TCR J 
alpha and IGH in lymphoid progenitors. 
The TCL1 is also activated in the majority of the 
cases of B cell lymphoma. 
Although rearrangement of MYC has not been 
demonstrated, cell from T-PLL with trisomy 8 or 
iso(8)(q10) overexpress the MYC protein. It is then 
possible that a high expression of c-myc plays a role 
in disease progression as a secondary event. 
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